Robert Malasek - 23 Sep 2022 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXIM	Option	Award	$0	+500,000	+167%	$0.000000	800,000	23 Sep 2022	Common Stock	500,000	$0.0520	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Reporting Person acquired an option to purchase up to 500,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date.